Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

NASDAQ:FRPT - Nasdaq - US3580391056 - Common Stock - Currency: USD

72.2916  -1.98 (-2.66%)

Fundamental Rating

4

FRPT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. FRPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRPT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FRPT was profitable.
FRPT had a positive operating cash flow in the past year.
FRPT had negative earnings in 4 of the past 5 years.
Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

With a Return On Assets value of 1.00%, FRPT is not doing good in the industry: 60.67% of the companies in the same industry are doing better.
FRPT's Return On Equity of 1.49% is on the low side compared to the rest of the industry. FRPT is outperformed by 60.67% of its industry peers.
FRPT has a Return On Invested Capital (1.94%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1%
ROE 1.49%
ROIC 1.94%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

FRPT has a Profit Margin of 1.54%. This is comparable to the rest of the industry: FRPT outperforms 42.70% of its industry peers.
FRPT has a Operating Margin of 3.58%. This is comparable to the rest of the industry: FRPT outperforms 51.69% of its industry peers.
FRPT has a Gross Margin of 40.63%. This is amongst the best in the industry. FRPT outperforms 92.13% of its industry peers.
FRPT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) 1.54%
GM 40.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

FRPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FRPT has been increased compared to 1 year ago.
FRPT has more shares outstanding than it did 5 years ago.
FRPT has a better debt/assets ratio than last year.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.98 indicates that FRPT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.98, FRPT belongs to the top of the industry, outperforming 86.52% of the companies in the same industry.
FRPT has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
FRPT's Debt to Equity ratio of 0.41 is in line compared to the rest of the industry. FRPT outperforms 53.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 4.98
ROIC/WACC0.2
WACC9.73%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.91 indicates that FRPT has no problem at all paying its short term obligations.
The Current ratio of FRPT (4.91) is better than 95.51% of its industry peers.
A Quick Ratio of 3.92 indicates that FRPT has no problem at all paying its short term obligations.
The Quick ratio of FRPT (3.92) is better than 95.51% of its industry peers.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.92
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 266.67% over the past year.
FRPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.25%.
FRPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.72% yearly.
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.68%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%17.6%

3.2 Future

Based on estimates for the next years, FRPT will show a very strong growth in Earnings Per Share. The EPS will grow by 38.68% on average per year.
Based on estimates for the next years, FRPT will show a quite strong growth in Revenue. The Revenue will grow by 18.65% on average per year.
EPS Next Y39.42%
EPS Next 2Y54.05%
EPS Next 3Y44.51%
EPS Next 5Y38.68%
Revenue Next Year15.83%
Revenue Next 2Y17.26%
Revenue Next 3Y17.83%
Revenue Next 5Y18.65%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

FRPT is valuated quite expensively with a Price/Earnings ratio of 109.53.
FRPT's Price/Earnings is on the same level as the industry average.
FRPT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.32.
The Price/Forward Earnings ratio is 32.41, which means the current valuation is very expensive for FRPT.
The rest of the industry has a similar Price/Forward Earnings ratio as FRPT.
When comparing the Price/Forward Earnings ratio of FRPT to the average of the S&P500 Index (22.13), we can say FRPT is valued slightly more expensively.
Industry RankSector Rank
PE 109.53
Fwd PE 32.41
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FRPT is valued a bit more expensive than 62.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.87
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as FRPT's earnings are expected to grow with 44.51% in the coming years.
PEG (NY)2.78
PEG (5Y)N/A
EPS Next 2Y54.05%
EPS Next 3Y44.51%

0

5. Dividend

5.1 Amount

No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield N/A

FRESHPET INC

NASDAQ:FRPT (6/16/2025, 1:58:09 PM)

72.2916

-1.98 (-2.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-05 2025-05-05/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners121.74%
Inst Owner Change11.19%
Ins Owners1.67%
Ins Owner Change10.4%
Market Cap3.53B
Analysts80.83
Price Target118.21 (63.52%)
Short Float %14.28%
Short Ratio4.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.34%
Min EPS beat(2)-8.85%
Max EPS beat(2)-1.83%
EPS beat(4)2
Avg EPS beat(4)36.84%
Min EPS beat(4)-8.85%
Max EPS beat(4)120.73%
EPS beat(8)6
Avg EPS beat(8)113.89%
EPS beat(12)7
Avg EPS beat(12)57.13%
EPS beat(16)7
Avg EPS beat(16)12.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.05%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)8
Avg Revenue beat(16)-0.39%
PT rev (1m)-2.21%
PT rev (3m)-25.29%
EPS NQ rev (1m)-2.54%
EPS NQ rev (3m)-24.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.29%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-6.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.33%
Valuation
Industry RankSector Rank
PE 109.53
Fwd PE 32.41
P/S 3.48
P/FCF N/A
P/OCF 22.94
P/B 3.36
P/tB 3.36
EV/EBITDA 32.87
EPS(TTM)0.66
EY0.91%
EPS(NY)2.23
Fwd EY3.09%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)3.15
OCFY4.36%
SpS20.8
BVpS21.51
TBVpS21.51
PEG (NY)2.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1%
ROE 1.49%
ROCE 2.46%
ROIC 1.94%
ROICexc 2.32%
ROICexgc 2.32%
OM 3.58%
PM (TTM) 1.54%
GM 40.63%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 3.67
Cap/Depr 210.1%
Cap/Sales 16.47%
Interest Coverage 3.82
Cash Conversion 132.7%
Profit Quality N/A
Current Ratio 4.91
Quick Ratio 3.92
Altman-Z 4.98
F-Score7
WACC9.73%
ROIC/WACC0.2
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.68%
EPS Next Y39.42%
EPS Next 2Y54.05%
EPS Next 3Y44.51%
EPS Next 5Y38.68%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%17.6%
Revenue Next Year15.83%
Revenue Next 2Y17.26%
Revenue Next 3Y17.83%
Revenue Next 5Y18.65%
EBIT growth 1Y2032.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year390.83%
EBIT Next 3Y101.99%
EBIT Next 5Y67%
FCF growth 1Y94.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y792.92%
OCF growth 3Y519.17%
OCF growth 5Y56.72%